The upregulated inflammatory pathways in CCCA (Figure 3F) include atherosclerosis and integrin signaling, lipid antigen presentation by CD1, CD28 signaling in T helper cells and NFkB and JAK/Stat signaling. This evidence concerns the gene CD28 and atherosclerosis.